Status:
RECRUITING
Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery
Lead Sponsor:
University of British Columbia
Collaborating Sponsors:
Canadian Cancer Society (CCS)
Canadian Institutes of Health Research (CIHR)
Conditions:
Salpingectomy
Colorectal Surgery
Eligibility:
FEMALE
15-80 years
Phase:
NA
Brief Summary
This study aims to evaluate the feasibility, safety and cost-effectiveness of opportunistic salpingectomy (OS-the removal of the fallopian tubes) at the time of colorectal surgery to prevent ovarian c...
Detailed Description
Research design: 120 eligible participants will be enrolled and consented to undergo OS at the time of colorectal surgery. As a control group, 120 participants undergoing colorectal surgery without O...
Eligibility Criteria
Inclusion
- Individuals with intact fallopian tubes.
- Individuals undergoing one of the following open or laparoscopic colorectal surgery: total colectomy, right hemicolectomy, left hemicolectomy, anterior resection, low anterior resection, small bowel resection and appendectomy.
- Individuals who finished with childbearing.
Exclusion
- Presence of BRCA 1 or 2 mutation.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05300711
Start Date
June 20 2022
End Date
March 1 2026
Last Update
February 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
2
Vancouver General Hospital
Vancouver, British Columbia, Canada